“HeartSine iECG - HeartSine Technologies.” GovInfoNow, updated October 14, 2026. https://govinfonow.com/recall/1449510-heartsine-technologies-ltd-recalls-heartsine-samaritan-pad-public-access-defibrillator. Based on FDA recall #Z-3270-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3270-2026%22&limit=1).
The FDA has issued a voluntary Class III recall for specific lots of HeartSine 350P US Device, US English (American Airlines) - 2 Min CPR automated external defibrillators due to a damaged membrane tail that causes an intermittent fault.
How to tell if you have it
HeartSine Technologies Ltd
FDA
The hazard
Due to a damaged (over stretched) membrane tail that causes an intermittent fault, the device may not function properly.
Context
This recall involves specific lots identified by codes including J23 23G90102822J23, K23 23G90102375K23, and others listed in the official documentation. HeartSine Technologies Ltd has 7 other recalls on record since 2023-02-01.
How to tell if you have this one
Check for the presence of the HeartSine iECG device in the patient's home or hospital.
Check for the presence of the HeartSine iECG device in the patient's home or hospital.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 46 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “U.S. Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 2 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-3270-2026 (July 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3270-2026 to see it in context.
Plain-language summary written by qwen3:4b on October 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.